PathMap Literature Based Discovery Engine

Share your Discovery:

Guaranteed to find unpublished literature based discoveries.

Clear Search

Experiment #00000080

Prenatal iron deficiency (ID) exacerbates the risk of sudden infant death syndrome (SIDS) by modulating the expression of the hypothalamic orexin system, impairing homeostatic arousal mechanisms during hypoxia.

Anemia, Iron-Deficiency _gates_from_anemia__iron_deficiency Hypothalamic-Hypophyseal System _gates_to_hypothalamic_hypophyseal_system _gates_from_hypothalamic_hypophyseal_system Sudden Infant Death _gates_to_sudden_infant_death _gates_from_sudden_infant_death Orexins _gates_to_orexins
View Results
Experiment #00000079

Why do seemingly perfectly healthy infants suddenly pass away in their sleep?

Infant, Newborn _gates_from_infant__newborn Autonomic Nervous System _gates_to_autonomic_nervous_system _gates_from_autonomic_nervous_system Death, Sudden _gates_to_death__sudden _gates_from_death__sudden Sudden Infant Death _gates_to_sudden_infant_death
View Results
Experiment #00000077

The use of lysosome-acidifying nanoparticles (AcNPs) could potentially be adapted to treat nanoplastic-induced lysosomal alkalization or membrane rigidification, as these nanoparticles act to restore the degradative capacity lost during environmental contaminant stress.

Nanoplastic exposure _gates_from_nanoplastic_exposure Lysosomes _gates_to_lysosomes _gates_from_lysosomes Autophagy _gates_to_autophagy Nanoparticles _gates_from_nanoparticles Hydrogen-Ion Concentration
View Results
Experiment #00000076

Nanoplastic-induced lysosomal membrane remodeling may sequester WDR44, creating a 'hotspot' for α-synuclein aggregation initiation.

Nanoplastics internalization _gates_from_nanoplastics_internalization Lysosomal accumulation _gates_to_lysosomal_accumulation _gates_from_lysosomal_accumulation Lysosomal Membranes _gates_to_lysosomal_membranes WDR44 _gates_from_wdr44 WDR44 protein
View Results
Experiment #00000075

Polystyrene nanoplastics (PS-NPs) may act as a scaffold for the recruitment and accumulation of WDR44 at the lysosomal membrane, thereby accelerating the de novo aggregation of alpha-synuclein in the early stages of PD.

Nanoplastic exposure _gates_from_nanoplastic_exposure Lysosomal Storage Diseases _gates_to_lysosomal_storage_diseases _gates_from_lysosomal_storage_diseases alpha-Synuclein _gates_to_alpha_synuclein WDR44 _gates_from_wdr44 Protein Aggregates
View Results
Experiment #00000074

OGT (O-GlcNAc transferase) modulation via pharmacological agonists can prevent degeneration of cranial nerves following traumatic or surgical stress.

Trauma/Stress _gates_from_trauma_stress Ferritinophagy/Oxidative Stress _gates_to_ferritinophagy_oxidative_stress Autophagy _gates_from_autophagy N-Acetylglucosaminyltransferases _gates_to_n_acetylglucosaminyltransferases _gates_from_n_acetylglucosaminyltransferases Neuronal Survival
View Results
Experiment #00000073

Can botulinum toxin A (BTX-A) be repurposed from cosmetic/spasticity applications in order to treat oculomotor palsy and have utilization with endoscopic endonasal approaches to skull base tumors to protect cranial nerves?

Botulinum Toxins, Type A _gates_from_botulinum_toxins__type_a Muscle Relaxation _gates_to_muscle_relaxation _gates_from_muscle_relaxation Neuroprotection _gates_to_neuroprotection Oculomotor Nerve Diseases _gates_from_oculomotor_nerve_diseases BTX-A
View Results
Experiment #00000072

Breakthroughs is bulbar palsy found in PubMed Literature, July 2026.

Bulbar Palsy _gates_from_bulbar_palsy Nerve Block _gates_to_nerve_block Elasticity Imaging Techniques _gates_to_elasticity_imaging_techniques Respiratory Failure _gates_to_respiratory_failure Therapeutic/Diagnostic Breakthroughs _gates_to_therapeutic_diagnostic_breakthroughs
View Results
Experiment #00000071

Do any recent non-proliferative diabetic retinopathy clinical trials reveal anything about Amyotrophic Lateral Sclerosis?

Diabetic Retinopathy _gates_from_diabetic_retinopathy ALS _gates_to_als Retinal Diseases _gates_to_retinal_diseases _gates_from_retinal_diseases Neurodegenerative Diseases _gates_to_neurodegenerative_diseases _gates_from_neurodegenerative_diseases
View Results
Experiment #00000070

What types of infections might cause a high C-Reactive Protein result?

Pathogen presence _gates_from_pathogen_presence Immunity, Innate _gates_to_immunity__innate _gates_from_immunity__innate C-Reactive Protein _gates_to_c_reactive_protein _gates_from_c_reactive_protein Biomarkers _gates_to_biomarkers
View Results
Experiment #00000068

ALS; FUS; STMN2; TDP-43; protein translation; stress granule

Cell Nucleus _gates_from_cell_nucleus RNA Splicing _gates_to_rna_splicing _gates_from_rna_splicing Protein Biosynthesis _gates_to_protein_biosynthesis _gates_from_protein_biosynthesis Motor Neuron Disease _gates_to_motor_neuron_disease
View Results
Experiment #00000067

Frontotemporal dementia; Splicing; TDP-43; Transcriptomics.

DNA-Binding Protein-43 _gates_from_dna_binding_protein_43 RNA Splicing _gates_to_rna_splicing _gates_from_rna_splicing Neuronal dysfunction _gates_to_neuronal_dysfunction Exons _gates_to_exons Splicing defects
View Results
Experiment #00000066

Are there any wellness alternatives for Von Willebrand Disease?

von Willebrand Diseases _gates_from_von_willebrand_diseases Multidisciplinary Care _gates_to_multidisciplinary_care _gates_from_multidisciplinary_care Transcutaneous Electric Nerve Stimulation _gates_to_transcutaneous_electric_nerve_stimulation Electric Stimulation Therapy _gates_to_electric_stimulation_therapy _gates_from_electric_stimulation_therapy
View Results
Experiment #00000065

Does pathologically seeded TDP-43 exit the retina via anterograde axonal transport along the optic tract to midbrain hubs, enter the systemic circulation inside extracellular vesicles, and subsequently traffic into pancreatic beta-cells to accelerate type 2 diabetes phenotypes?

TAR DNA-Binding Protein 43 _gates_from_tar_dna_binding_protein_43 Extracellular Vesicles _gates_to_extracellular_vesicles Systemic circulating EVs _gates_from_systemic_circulating_evs Insulin-Secreting Cells _gates_to_insulin_secreting_cells Axonal Transport _gates_to_axonal_transport
View Results
Experiment #00000064

Lon Protease, Alternaria; IL-33; TSLP; alarmins; asthma; chronic rhinosinusitis; fungal allergen; innate lymphoid cells

Alternaria _gates_from_alternaria Alarmins _gates_to_alarmins _gates_from_alarmins Immunity, Innate _gates_to_immunity__innate _gates_from_immunity__innate Lon-Peptidase _gates_to_lon_peptidase
View Results
Experiment #00000063

What specific structural modifications to the pyrrolidinone scaffold led to improved potency against SARM1 compared to earlier inhibitor classes?

Pyrrolidinones _gates_from_pyrrolidinones SARM1 _gates_to_sarm1 Sterile Alpha and TIR Motif Containing 1 _gates_from_sterile_alpha_and_tir_motif_containing_1 Axonal Degeneration _gates_to_axonal_degeneration Molecular Structure _gates_from_molecular_structure
View Results
Experiment #00000062

NESCO-induced pyroptosis in the peritoneal microenvironment might be attenuated by the upregulation of 11-oxygenated androgens in the systemic circulation.

Endometriosis _gates_from_endometriosis Tumor Microenvironment _gates_to_tumor_microenvironment Androgens _gates_from_androgens _gates_to_endometriosis Disease Models, Animal _gates_from_disease_models__animal NESCO and Androgens
View Results
Experiment #00000061

Breakthroughs in Endometriosis Research Discovered in PubMed Literature: July 2026 Edition

Cellular Reprogramming _gates_from_cellular_reprogramming Biological Phenomena _gates_to_biological_phenomena _gates_from_biological_phenomena Drug Resistance _gates_to_drug_resistance
View Results
Experiment #00000059

Amyotrophic lateral sclerosis; Biomarkers; Clinical trials; Neuron-derived extracellular vesicles; Neuropathology; Pharmacodynamic biomarkers; Surrogate endpoints; TDP-43

Disease Progression _gates_from_disease_progression Biological Markers _gates_to_biological_markers _gates_from_biological_markers Proteomics _gates_to_proteomics Platform Data _gates_from_platform_data Patient Selection
View Results
Experiment #00000057

Amyotrophic Lateral Sclerosis breakthrough updates as of July 2026

Systemic Disease _gates_from_systemic_disease Gene Expression Regulation _gates_to_gene_expression_regulation
View Results
Experiment #00000056

Sarcopenia and Amyotrophic Lateral Sclerosis: Biological Pathways and Analysis

Motor Neuron Disease _gates_from_motor_neuron_disease Neuromuscular Junction Diseases _gates_to_neuromuscular_junction_diseases _gates_from_neuromuscular_junction_diseases Muscle Weakness _gates_to_muscle_weakness NMJ instability _gates_from_nmj_instability Sarcopenia
View Results
Experiment #00000055

If the RGNEF NF 242 Terminal loses its functional ability to agitate or compete with TDP-43, perhaps from misfolding or sequestration, could it cause the TDP-43 proteinopathy seen in the retina, post-mortem, in Sporadic Amyotrophic Lateral Sclerosis patients, if the RGNEF failures were localized in the retina?

RGNEF/NF242 _gates_from_rgnef_nf242 TDP-43 _gates_to_tdp_43 Rho Guanine Nucleotide Exchange Factor _gates_from_rho_guanine_nucleotide_exchange_factor TDP-43 Proteinopathies _gates_to_tdp_43_proteinopathies Amyotrophic Lateral Sclerosis _gates_from_amyotrophic_lateral_sclerosis
View Results
Experiment #00000054

What dietary habits are beneficial towards reducing excess/harmful tyramine in order to improve liver and gut health?

Dietary Proteins _gates_from_dietary_proteins Aromatic-L-Amino-Acid Decarboxylases _gates_to_aromatic_l_amino_acid_decarboxylases _gates_from_aromatic_l_amino_acid_decarboxylases Tyramine _gates_to_tyramine _gates_from_tyramine Gastrointestinal Diseases _gates_to_gastrointestinal_diseases
View Results
Experiment #00000053

How do specific microbial-derived metabolites, beyond short-chain fatty acids and bile acids, function as 'molecular switches' to program hepatic lipid metabolism during the earliest stages of steatotic liver disease?

Microbial composition _gates_from_microbial_composition Metabolomics _gates_to_metabolomics _gates_from_metabolomics Signal Transduction _gates_to_signal_transduction Host signaling _gates_from_host_signaling Lipid Metabolism
View Results
Experiment #00000052

Can fatty liver disease be treated in order to restore gut health?

MASLD pathophysiology _gates_from_masld_pathophysiology Gastrointestinal Microbiome _gates_to_gastrointestinal_microbiome _gates_from_gastrointestinal_microbiome Farnesoid X-Activated Receptor _gates_to_farnesoid_x_activated_receptor _gates_from_farnesoid_x_activated_receptor Intestinal Mucosa _gates_to_intestinal_mucosa
View Results
Experiment #00000051

Is TDP-43 proteinopathy associated with toxoplasmosis?

Datasets as Topic _gates_from_datasets_as_topic Toxoplasmosis or Toxoplasma gondii _gates_to_toxoplasmosis_or_toxoplasma_gondii TAR DNA-Binding Protein 43 _gates_from_tar_dna_binding_protein_43 _gates_to_datasets_as_topic Toxoplasmosis _gates_from_toxoplasmosis Not Found
View Results
Experiment #00000050

What are the symptoms of toxoplasmosis and how is it transmitted?

Host _gates_from_host Infection _gates_to_infection _gates_from_infection Clinical Symptoms _gates_to_clinical_symptoms Animals, Domestic _gates_from_animals__domestic Environment
View Results
Experiment #00000049

Explain the risks of veridical AI and human job displacement.

Artificial Intelligence _gates_from_artificial_intelligence Efficiency, Organizational _gates_to_efficiency__organizational _gates_from_efficiency__organizational Employment _gates_to_employment _gates_from_employment Patient-Centered Care _gates_to_patient_centered_care
View Results
Experiment #00000048

The ALS-T2D comorbidity is driven by a bidirectional, exosome-mediated proteostatic collapse. Peripheral tissues (muscle, pancreas) dictate CNS TDP-43 stability via exosomal miRNAs (miR-126a-5p) and glucose-dependent modifications (O-GlcNAcylation). Conversely, pharmacological activation of ubiquitin-peptidases (e.g., Acarbose targeting USP46) or restitution of glycolytic cofactors (F2,6BP) represent novel, cross-disciplinary therapeutic targets capable of halting systemic proteinopathy.

Diabetes Mellitus, Type 2 _gates_from_diabetes_mellitus__type_2 Extracellular Vesicles _gates_to_extracellular_vesicles _gates_from_extracellular_vesicles DNA-Binding Proteins _gates_to_dna_binding_proteins _gates_from_dna_binding_proteins Amyotrophic Lateral Sclerosis _gates_to_amyotrophic_lateral_sclerosis
View Results
Experiment #00000046

How does knitting help improve mental health?

Knitting _gates_from_knitting Psychophysiology _gates_to_psychophysiology _gates_from_psychophysiology Neurotransmitter Release _gates_to_neurotransmitter_release _gates_from_neurotransmitter_release Anxiety _gates_to_anxiety
View Results
Experiment #00000045

Sporadic ALS and C9orf72 affected ALS are two different pathologies and the mixing of test groups and datasets has produced confounding results.

Molecular Heterogeneity _gates_from_molecular_heterogeneity Diagnostic Errors _gates_to_diagnostic_errors Biomarkers _gates_to_biomarkers Genetic Heterogeneity _gates_from_genetic_heterogeneity Molecular Typing _gates_to_molecular_typing
View Results
Experiment #00000044

What kinds of changes in voice occur prior to Amyotrophic Lateral Sclerosis onset?

Amyotrophic Lateral Sclerosis _gates_from_amyotrophic_lateral_sclerosis Bulbar Palsy _gates_to_bulbar_palsy _gates_from_bulbar_palsy Speech _gates_to_speech _gates_from_speech Missing _gates_to_missing
View Results
Experiment #00000043

Subject-specific prognostic models can now predict articulatory precision and ALSFRS-R speech subscores 30–90 days in advance.

Speech-Language Pathology _gates_from_speech_language_pathology Algorithms _gates_to_algorithms _gates_from_algorithms Amyotrophic Lateral Sclerosis _gates_to_amyotrophic_lateral_sclerosis Speech _gates_from_speech Bulbar Palsy
View Results

See all pathway research


Need a custom Literature-Based Discovery?

Get 1-3 unpublished, new, novel, real and non-implausible literature based discoveries with each order of a PathMap Evaluation (3x) package.

Order a custom PathMap Evaluation (3x) - $29.99